Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 7, 2011
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patientsGuido H van Welsenes, Johannes B van Rees, C Jan Willem Borleffs, et al.Journal of Cardiovascular Electrophysiology|July 23, 2011
Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-lifeGuido H Van Welsenes, Johannes B Van Rees, Joep Thijssen, et al.Journal of the American College of Cardiology|February 27, 2010
Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patientsC Jan Willem Borleffs, Johannes B van Rees, Guido H van Welsenes, et al.Circulation. Arrhythmia and Electrophysiology|October 22, 2009
Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angleC Jan Willem Borleffs, Roderick W C Scherptong, Sum-Che Man, et al.Pacing and Clinical Electrophysiology : PACE|February 23, 2012
Update on small-diameter implantable cardioverter-defibrillator leads performanceJohannes B van Rees, Guido H van Welsenes, C Jan Willem Borleffs, et al.Pacing and Clinical Electrophysiology : PACE|May 12, 2010
Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complicationsC Jan Willem Borleffs, Joep Thijssen, Mihály K de Bie, et al.Heart (British Cardiac Society)|May 15, 2012
Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk scoreJohannes B van Rees, C Jan Willem Borleffs, Guido H van Welsenes, et al.European Heart Journal|November 26, 2009
Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart diseaseC Jan Willem Borleffs, Guido H van Welsenes, Rutger J van Bommel, et al.Pageof 1